performance report · performance report . mark garrick . director of strategy and quality...

22
Performance Report Mark Garrick Director of Strategy and Quality Development

Upload: others

Post on 03-Jul-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

Performance Report

Mark Garrick Director of Strategy and

Quality Development

Page 2: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

Material exceptions to report

Page 3: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Overall Trust performance improved to 67.2%.

• Attendances fell significantly as the public became aware of the risks relating to COVID-19.

• Overall, 10.1% of patients who attended in March had ‘COVID-19 like’ diagnoses.

• Ask A&E was used 1,294 times in March. Utilisation increased towards the end of the month and into April.

• 812 (62.8%) patients using Ask A&E were redirected to another service.

• Good Hope had one 12-hour trolley wait in March. The patient was awaiting a mental health bed.

3

118

110Responsible Director: Chief Operating Officer 80.7% Target:

Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Mar 20 YTD

QEHB T1 57.6% 62.2% 70.8% 64.4% 62.0% 63.2% 62.1% 57.8% 60.3% 58.1% 59.0% 58.6% 67.7% 62.1%

BHH T1 72.8% 68.2% 65.4% 65.1% 68.1% 68.9% 64.8% 64.4% 62.3% 59.8% 62.1% 60.9% 57.9% 64.1%

GHH T1 68.7% 67.8% 64.4% 66.1% 69.1% 69.2% 65.5% 65.8% 61.3% 60.2% 63.3% 60.8% 65.4% 64.9%

Solihull T3 99.0% 98.3% 98.6% 98.1% 98.4% 98.5% 98.1% 98.3% 96.9% 96.7% 97.0% 96.7% 97.6% 97.8%

UHB T1 & 3 69.8% 69.2% 70.2% 68.5% 69.7% 70.2% 67.5% 66.0% 64.7% 62.8% 66.0% 65.3% 67.2% 67.3%

System T1 & 3 80.6% 80.3% 80.7% 79.3% 80.0% 80.6% 78.6% 77.9% 77.3% 76.4% 77.8% 77.1% 77.4% 79.0%

NHS Oversight Framework Latest mth trajectory: 95%

A&E 4 Hour Wait Performance

Daily Average Attendances

National Rank (of 118 T1 Trusts)

67.2%77.4%UHB system

UHB trustLatest Month:A&E 4 Hour Waits

50%

60%

70%

80%

90%

100%

Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Mar 20

UHB T1 & 3 System T1 & 3 QEHB T1 BHH T1 GHH T1

Solihull T3 Shelford T1 England T1 Target Trajectory

800

900

1000

1100

1200

Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Mar 20

Page 4: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Overall incomplete RTT performance deteriorated to 79.2%, which is below the trajectory of 87.8%.

• Key issues in February were emergency demand on beds and reduced additional sessions due to pension tax.

• Cancellations of elective surgery and outpatient appointments in response to COVID-19 will significantly affect future performance.

• Neurology improved compared to January with additional capacity resulting in a reduction in the backlog.

• Neurosurgery slightly deteriorated and continued to have a large volume of patients awaiting triage.

4

Responsible Director: Chief Operating Officer 87.8% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 86.3% 86.5% 86.4% 86.5% 85.6% 85.2% 84.1% 83.6% 83.2% 82.6% 81.0% 80.4% 79.2% 83.4%

RTT Incomplete Pathways

RTT Incomplete Pathway Performance

Latest mth trajectory: 92%

Latest Month: 79.2%NHS Oversight Framework

General Surg

Urology

ENT

Ophthalmology

Neurosurgery

Cardiothoracics

Neurology

England

UHB

Trajectory

50%

55%

60%

65%

70%

75%

80%

85%

90%

95%

100%

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20

Page 5: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• The RTT waiting list size grew in February by 1,215.

• It is now 8,826 (10.2%) above the baseline.

• The number of patients waiting longer than 40 weeks continued to grow.

• Both the number of waiting list additions and removals will reduce from March, linked to COVID-19.

• One 52 week breach was recorded in Ophthalmology with the RCA still to be finalised. The patient was treated early March.

• Nationally the waiting list grew to 4.43m which is 15.1% above the baseline.

5

Responsible Director: Chief Operating Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Change

UHB 85,815 85,975 87,233 88,782 88,675 89,541 89,915 91,080 92,490 92,735 92,957 94,304 95,519 +8,826

≤ 86,693

RTT Waiting List Size Latest Month: 95,519Planning Guidance

RTT - Waiting List Size

3.5m

3.7m

3.9m

4.1m

4.3m

4.5m

4.7m

4.9m

5.1m

5.3m

5.5m

70,000

75,000

80,000

85,000

90,000

95,000

100,000

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Engl

and

Wai

tin

g Li

st S

ize

UH

B W

aiti

ng

List

Siz

e

UHB UHB Baseline England England Baseline

Page 6: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Overall performance improved to 97.3%.

• The main areas of concern were Endoscopy, Cardiac CT capacity and Imaging.

• CT continued to experience pressure due to the demand for the service exceeding the available capacity.

• Ultrasound breaches reduced significantly with just one breach in February.

• Pressure on Endoscopy continued with further short-term deterioration in performance likely as plans to tackle colorectal 2ww backlog are implemented.

6

Responsible Director: Chief Operating Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

Colonoscopy 97.9% 94.7% 96.1% 96.6% 94.6% 91.7% 96.6% 87.1% 93.3% 94.2% 90.0% 79.0% 84.5% 91.1%

Cystoscopy 98.6% 94.0% 92.4% 90.3% 94.2% 96.2% 95.7% 88.9% 94.0% 94.0% 90.1% 87.3% 95.0% 92.6%

Flexisig 97.6% 88.5% 98.0% 96.2% 94.5% 90.6% 93.7% 93.9% 96.6% 94.6% 81.3% 73.6% 79.5% 90.3%

Gastroscopy 99.0% 94.4% 98.8% 98.5% 97.3% 93.8% 90.3% 95.8% 96.2% 94.8% 91.6% 82.9% 87.2% 93.3%

UHB 99.5% 98.9% 99.1% 99.0% 99.1% 98.6% 97.9% 98.0% 98.8% 98.8% 96.4% 96.6% 97.3% 98.2%

Latest Month: 97.3%99%

6 Week Diagnostics

6 Week Diagnostics Performance

NHS Oversight Framework

UHBEngland

Colonoscopy

Flexisig

Gastroscopy

Urodynamics

30%

40%

50%

60%

70%

80%

90%

100%

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20

Page 7: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Overall activity per working day fell by 6.9pp in February compared to the previous month.

• Daycase and Emergency activity per working day fell by 0.7pp and 3.8pp, respectively.

• Elective activity increased by 9.5pp.

7

Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Latest

Daycases 545 572 624 610 530 521 544 532 526 557 556 556 552 552

Elective 110 121 119 122 108 102 110 104 101 102 103 99 109 109

Emergency 355 358 426 419 412 429 402 412 427 432 427 419 403 403

Activity - Daycases & Electives per Working Day, Emergencies per Day

Activity

0

100

200

300

400

500

600

700

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Elective Daycases Emergency

Page 8: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• The overall percentage of NHS and joint delays deteriorated to 2.3%. • However, the total percentage delay remained static at 4.7%. • QEHB had an improvement in overall delayed transfer of care, whilst Heartlands and Solihull performance

deteriorated. Good Hope largely remained static at 5.5%. • Solihull performance deteriorated by 2.3pp to 8.1 %. The deterioration is partly due to an increase of 174% in

Birmingham City Council delays. The NHS and Joint delays performance also deteriorated at the site.

8

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB 1.6% 2.4% 1.8% 1.8% 1.6% 1.8% 2.3% 2.7% 2.1% 1.9% 1.7% 1.8% 1.7% 1.9%

BHH 3.0% 1.7% 1.9% 2.2% 2.4% 3.5% 2.7% 3.3% 2.6% 3.1% 1.9% 2.4% 2.4% 2.6%

GHH 2.4% 2.4% 2.0% 1.4% 1.5% 1.7% 1.9% 1.7% 1.8% 1.9% 1.7% 1.8% 2.4% 1.8%

Solihull 3.9% 2.8% 2.5% 2.9% 3.2% 3.5% 3.4% 4.0% 3.0% 3.6% 4.8% 3.8% 4.9% 3.6%

UHB 2.3% 2.2% 1.9% 1.9% 1.9% 2.4% 2.4% 2.8% 2.2% 2.4% 2.0% 2.1% 2.3% 2.2%

Responsible Director: Chief Operating Officer

2.3%Delayed Transfers of Care (NHS & Joint)

Delayed Transfers of Care (Bed Days)

Latest Month:

Target: 1.4%

0

1

2

3

#REF! #REF!

0.0%

1.0%

2.0%

3.0%

4.0%

5.0%

6.0%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB QEHB BHH GHH Sol

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB 4.0% 4.6% 2.9% 2.6% 2.7% 3.1% 4.6% 4.1% 3.6% 3.8% 2.7% 3.8% 2.9% 3.3%

BHH 5.9% 4.3% 3.1% 3.6% 4.5% 5.2% 5.3% 5.9% 5.8% 5.7% 5.2% 5.5% 6.1% 5.1%

GHH 5.7% 6.3% 4.8% 3.0% 3.4% 5.5% 6.2% 5.6% 6.8% 6.7% 6.2% 5.4% 5.5% 5.3%

Solihull 8.3% 7.7% 4.7% 5.8% 5.5% 6.8% 5.9% 7.8% 8.7% 6.4% 7.1% 5.8% 8.1% 6.6%

UHB 5.2% 5.1% 3.5% 3.2% 3.6% 4.5% 5.2% 5.2% 5.2% 5.1% 4.5% 4.7% 4.7% 4.5%

Target: 3.0%

Delayed Transfers of Care (All) 4.7%Responsible Director: Chief Operating Officer

Latest Month:

Delayed Transfers of Care (Bed Days)

0

1

2

3

#REF! #REF!

0.0%

1.0%

2.0%

3.0%

4.0%

5.0%

6.0%

7.0%

8.0%

9.0%

10.0%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB QEHB BHH GHH Sol

Page 9: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• 337 operations were cancelled on the day of surgery in February, compared to 344 in January. • There were ten breaches of the 28 day guarantee with seven of the breaches at QEHB and three at Heartlands. • QEHB had three breaches in Neurosurgery, two in Urology and one each in Neurology and ENT. • Heartlands had two of the breaches in Vascular Surgery with the third breach in General Surgery. • The majority of the breaches and cancellations were due to capacity issues and increased site pressures. • Eight of the patients have been treated whilst the remaining two have been removed from the waiting list.

9

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB 2.0% 2.6% 3.3% 2.8% 2.7% 2.7% 2.2% 3.4% 2.7% 3.9% 4.0% 4.2% 3.3% 3.2%

BHH 1.8% 1.8% 2.3% 2.4% 2.8% 2.0% 2.3% 2.6% 3.1% 2.3% 2.5% 2.4% 4.1% 2.6%

GHH 1.0% 1.4% 0.6% 1.7% 0.7% 0.8% 0.6% 1.9% 2.5% 0.7% 0.7% 0.4% 0.9% 1.1%

Solihull 1.0% 0.8% 0.5% 1.1% 0.6% 0.7% 1.1% 0.7% 1.0% 0.7% 0.6% 0.9% 0.7% 0.8%

UHB 1.6% 1.8% 1.9% 2.1% 1.9% 1.7% 1.7% 2.3% 2.4% 2.2% 2.3% 2.3% 2.4% 2.1%

Responsible Director: Chief Operating Officer Target: 0.8%

Operations Cancelled on the Day of Surgery

Latest Month: 2.4%Operations Cancelled on the Day of Surgery

0.0%

0.5%

1.0%

1.5%

2.0%

2.5%

3.0%

3.5%

4.0%

4.5%

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20

Target UHB QEHB BHH GHH Solihull

Responsible Director: Chief Operating Officer

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB 5 5 4 6 4 10 5 4 4 9 4 8 7 65

BHH 6 1 0 2 0 2 1 1 3 3 5 1 3 21

GHH 0 0 0 2 0 0 0 0 0 0 0 0 0 2

Solihull 0 0 0 0 0 0 0 0 0 0 0 2 0 2

UHB 11 6 4 10 4 12 6 5 7 12 9 11 10 90Operations Cancelled on the Day of Surgery Not Rebooked within 28 days

Target:

100

Cancelled Operations Not Rebooked Within 28 days Latest Month:

0

2

4

6

8

10

12

14

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

QEHB BHH GHH Sol

Page 10: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• The Trust’s overall 62 day performance for GP referrals improved to 47.0%. Screening performance deteriorated by 13.8pp to 37.8%, against the monthly trajectory of 86.7%. All the screening breaches remain in Breast and Colorectal.

• Ongoing delays in diagnostic pathways due to capacity constraints are impacting on the treatment times for all patient groups, whether they have been referred via a GP or the screening service.

• Despite ongoing demand pressures, the Trust still delivered 233.5 accountable 62 day first treatments, an increase of nearly 20% compared to February 2019.

• Services retain close monitoring of shortfalls and backlog in order to mitigate risk and ensure patients remain safe.

10

Responsible Director: Chief Operating Officer 81.8% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 76.9% 72.2% 70.7% 69.6% 71.6% 63.0% 61.1% 59.3% 65.0% 59.7% 55.2% 46.7% 47.0% 60.9%

85%

Latest Month: 47.0%NHS Oversight Framework Latest mth trajectory:

Cancer - 62 Day GP Referral Performance

Cancer - 62 Day GP Referrals

40%

50%

60%

70%

80%

90%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England Trajectory

Responsible Director: Chief Operating Officer 86.7% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 89.8% 89.1% 89.7% 87.5% 79.1% 74.6% 91.7% 73.7% 60.9% 44.4% 66.0% 51.6% 37.8% 67.0%

90%NHS Oversight Framework Latest mth trajectory:

Latest Month:Cancer - 62 Day Screening 37.8%

Cancer - 62 Day Screening Performance

30%

40%

50%

60%

70%

80%

90%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England Trajectory

Page 11: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• 31 day first treatment performance improved by 1.2pp to 89.7%, against a monthly trajectory of 96.2%. • The majority of breaches were in Urology, where there remain theatre capacity constraints. This is followed by

Head and Neck, Colorectal and Breast with delays in the diagnostic phase of the pathway continuing to impact on treatment times.

• Subsequent surgery performance for the Trust improved to 79.8%. Ongoing elevated urgent care demand continued to place excessive pressures on ward and ITU beds available for elective cases.

11

Responsible Director: Chief Operating Officer 96.2% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 95.5% 95.1% 94.3% 93.5% 96.0% 91.5% 93.9% 91.6% 93.7% 90.5% 90.9% 88.5% 89.7% 92.2%

Cancer Access Latest mth trajectory:

Latest Month:

Cancer - 31 Day First Treatment Performance

89.7%

96%

Cancer - 31 Day First Treatment

88%

90%

92%

94%

96%

98%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England Trajectory

Responsible Director: Chief Operating Officer 94.5% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 99.2% 96.1% 93.8% 96.8% 92.0% 82.4% 85.9% 81.7% 86.6% 86.8% 89.7% 77.4% 79.8% 87.0%

Cancer - 31 day Subsequent Treatment (Surgery) Performance

Cancer - 31 Day Subsequent Treatment (Surgery)Cancer Access Latest mth trajectory:

Latest Month: 79.8%

94%

70%

75%

80%

85%

90%

95%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England Trajectory

Page 12: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• 2 week waits for suspected cancer deteriorated to 84.5% against a monthly trajectory of 92.3%. • Breast symptomatic performance deteriorated by 17.6pp to 48.6%. • Ongoing capacity shortfalls continued to affect Breast and Colorectal pathways. • However, capacity shortfalls did show signs of reducing, with fewer patients waiting for a first appointment to be

booked. • In total the Trust still managed to ensure that 3,426 patient were seen within 14 days of referral in February.

12

Responsible Director: Chief Operating Officer 92.3% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 83.0% 85.8% 86.2% 71.6% 72.6% 83.1% 80.3% 87.3% 85.5% 83.6% 80.0% 85.9% 84.5% 81.9%

84.5%Latest Month:

Cancer Access Latest mth trajectory: 93%

Cancer - 2 Week Wait (Suspected Cancer)

Cancer - 2 Week Wait (Suspected Cancer) Performance

70%

75%

80%

85%

90%

95%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England Trajectory

Responsible Director: Chief Operating Officer 88.1% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 70.4% 43.4% 51.8% 24.1% 17.4% 38.6% 69.7% 75.1% 81.1% 67.4% 39.7% 66.2% 48.6% 53.5%

Cancer Access Latest mth trajectory:

Cancer - 2 Week Wait (Breast Symptoms) Latest Month: 48.6%

93%

Cancer - 2 Week Wait (Breast Symptoms) Performance

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20Target UHB England Trajectory

Page 13: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• The March 2020 target of reducing the number of patients with a length of stay of 21 days or more has been set at 327.

• The number of these patients remained static in February compared to the previous month.

• Although slight progress has been made on achieving the target, the Trust will not be able to meet the target by the deadline, based on the current performance.

13

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Latest

QEHB 259 273 267 255 215 253 244 246 249 261 273 268 253 253

BHH 115 106 117 104 96 131 94 112 113 113 125 103 116 116

GHH 100 98 84 99 101 75 83 105 96 88 99 84 83 83

Solihull 53 22 31 29 22 31 38 31 29 27 46 32 35 35

UHB 527 499 499 487 434 490 459 494 487 489 543 487 487 487

327 by Mar 2020

Occupied beds of all discharged adult patients in hospital for 21+ days

Latest Month:Occupied beds of all discharged adult patients in hospital for 21+ days

Target:Responsible Director: Chief Operating Officer

487

0

100

200

300

400

500

600

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

UHB Target QEHB BHH GHH Solihull

Page 14: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• There were no mixed sex accommodation breaches in February.

14

Responsible Director: Chief Nurse

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB 0 0 0 0 0 0 0 0 0 0 0 0 0 0

BHH 2 0 0 0 0 0 0 0 0 0 0 0 0 0

GHH 0 0 0 0 0 0 0 0 10 5 10 0 0 25

Solihull 0 0 0 0 0 0 0 0 0 0 0 0 0 0

UHB 2 0 0 0 0 0 0 0 10 5 10 0 0 25

Target: 0

Latest Month: 0Mixed Sex Accommodation

Mixed Sex Accommodation Breaches (Patients Affected)

0

1

2

3

4

5

6

7

8

9

10

11

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

QEHB BHH GHH Sol

Page 15: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

Staff Flu Vaccinations • To achieve the 80% target, 12,008 frontline staff needed to be

vaccinated by 28 February 2020. • An extension to the deadline to 31 March for the purposes of the

associated CQUIN was agreed with Birmingham and Solihull CCG. • As of 31 March, in total 11,579 staff have been vaccinated, 429 short of

the target. • The Trust’s final performance was 77.1%.

14

Page 16: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

Other targets and indicators for information

Page 17: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Performance for the “Find” element fell to 78.3%.

• QEHB remained the only site above target with performance of 93.4%.

• Heartlands, Good Hope and Solihull performance deteriorated.

• Performance at Heartlands and Good Hope fell by 3.9pp and 4.1pp, respectively.

• Solihull performance deteriorated by 12.0pp to 59.2%.

• The “Assess” element had a performance of 95.1% whilst “Refer” element continued to have excellent performance of 100%.

17

FindAssessRefer

Responsible Director: Medical Director Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB - Find 95.4% 94.8% 94.7% 97.2% 95.3% 95.6% 94.4% 93.5% 94.0% 94.1% 91.2% 94.2% 93.4% 94.3%

BHH - Find 89.9% 91.4% 85.9% 85.5% 84.9% 88.3% 84.6% 83.1% 82.8% 81.0% 81.9% 79.8% 75.9% 83.0%

GHH - Find 80.2% 78.6% 78.9% 74.9% 70.7% 77.4% 69.8% 77.6% 75.9% 73.7% 77.1% 76.9% 72.8% 75.1%

Solihull - Find 87.0% 87.2% 74.3% 78.6% 79.5% 79.4% 81.7% 69.8% 77.5% 66.7% 73.0% 71.2% 59.2% 73.6%

UHB - Find 88.3% 88.1% 84.9% 85.0% 83.0% 86.4% 83.3% 82.8% 83.4% 81.1% 82.4% 82.0% 78.3% 82.9%

QEHB - Assess 97.7% 100% 100% 100% 100% 100% 100% 100% 100% 100% 98.0% 100% 98.4% 99.6%

BHH - Assess 90.9% 95.5% 96.7% 100% 100% 97.1% 92.9% 95.5% 100% 100% 100% 96.0% 90.5% 97.4%

GHH - Assess 100% 100% 92.9% 100% 100% 100% 90.9% 92.9% 100% 100% 100% 100% 86.7% 96.8%

Sol - Assess 92.3% 100% 93.8% 100% 100% 100% 100% 100% 100% 100% 100% 80.0% 100% 98.3%

UHB - Assess 95.1% 98.8% 96.7% 100% 100% 98.9% 96.8% 97.6% 100% 100% 99.0% 97.6% 95.1% 98.4%

QEHB- Refer 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

BHH - Refer 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

GHH - Refer 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

Sol - Refer 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

UHB - Refer 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

90%

Dementia Finding, Assessment and Referral Latest Month: 95.1%100%

NHS Oversight Framework

78.3%

Dementia Finding Performance

50%

60%

70%

80%

90%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB QEHB BHH GHH Sol England

Page 18: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• 31 day subsequent chemotherapy performance remained above target at 98.7%. • 31 day subsequent radiotherapy performance improved to 94.7%.

Responsible Director: Chief Operating Officer 98.7% Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 99.3% 99.3% 98.1% 99.4% 99.4% 97.1% 100.0% 100.0% 100.0% 100.0% 96.3% 99.1% 98.7% 99.0%

98%Cancer Access

Cancer - 31 day Subsequent Treatment (Chemotherapy) Performance

Cancer - 31 Day Subsequent Treatment (Chemotherapy)

Latest mth trajectory:

Latest Month: 98.7%

91%

92%

93%

94%

95%

96%

97%

98%

99%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England

Responsible Director: Chief Operating Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

UHB 98.7% 97.7% 98.2% 94.4% 97.0% 95.2% 95.3% 94.6% 97.8% 95.6% 99.6% 94.5% 94.7% 96.0%

94%

Cancer - 31 day Subsequent Treatment (Radiotherapy) Performance

94.7%Cancer Access

Cancer - 31 Day Subsequent Treatment (Radiotherapy) Latest Month:

91%

92%

93%

94%

95%

96%

97%

98%

99%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB England

Page 19: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Performance for the Trust remained above target at 97.8%.

19

Responsible Director: Medical Director Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 YTD

QEHB 98.6% 98.5% 98.9% 99.1% 98.8% 98.8% 98.8% 98.8% 98.9% 98.5% 98.6% 98.9% 98.8% 98.8%

BHH 98.2% 97.9% 98.5% 98.2% 98.1% 98.0% 98.2% 98.0% 98.5% 99.2% 97.3% 96.7% 97.2% 97.9%

GHH 97.9% 97.8% 98.1% 98.2% 97.6% 98.0% 97.7% 97.8% 97.9% 98.9% 97.9% 97.0% 96.4% 97.8%

Sol 98.4% 98.8% 98.8% 98.8% 98.9% 99.0% 98.8% 98.7% 99.0% 99.4% 98.1% 97.7% 98.0% 98.6%

UHB 98.3% 98.2% 98.6% 98.6% 98.4% 98.4% 98.4% 98.4% 98.6% 98.9% 97.9% 97.7% 97.8% 98.3%VTE Screening

97.8%95%Clinical Quality

Latest Month:VTE Screening

94%

95%

96%

97%

98%

99%

100%

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20

Target UHB Delayed Transfers of Care (NHS & Joint) QEHB BHH GHH Sol

Page 20: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• The number of beds occupied by patients with a length of stay >7 days fell by 54 in February compared to the previous month.

20

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Latest

QEHB 590 595 574 583 489 551 561 564 568 556 599 612 575 575

BHH 337 318 373 337 319 379 317 340 359 350 376 384 370 370

GHH 277 274 274 274 274 274 274 274 274 274 274 274 274 274

Solihull 122 69 86 84 75 90 89 93 97 81 116 101 98 98

UHB 1,326 1,256 1,307 1,278 1,157 1,294 1,241 1,271 1,298 1,261 1,365 1,371 1,317 1,317Occupied beds of all discharged adult patients in hospital for 7+ days

Responsible Director: Chief Operating Officer

Occupied beds of all discharged adult patients in hospital for 7+ days Latest Month: 1,317

0

200

400

600

800

1,000

1,200

1,400

1,600

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20

UHB QEHB BHH GHH Solihull

Page 21: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Appraisal performance improved to 80.2%. • Corporate Induction had an excellent performance of 100%. • Cancellations of Appraisals and Induction in response to COVID-19 will affect future performance.

21

Responsible Director: Chief Innovation Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Latest

UHB 86.9% 86.5% 0.0% 0.0% 83.6% 83.1% 82.5% 80.8% 80.4% 79.9% 80.3% 79.7% 80.2% 80.2%

Appraisal Latest Month: 80.2%90%Workforce

Appraisal

76%

80%

84%

88%

92%

96%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB

Responsible Director: Chief Innovation Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Latest

UHB 98.0% 98.0% 0.0% 0.0% 90.1% 90.7% 93.5% 96.8% 96.9% 98.1% 97.3% 97.0% 100.0% 100.0%

Latest Month:

95%

Corporate Induction

Workforce

Corporate Induction 100.0%

60%

65%

70%

75%

80%

85%

90%

95%

100%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB

Page 22: Performance Report · Performance Report . Mark Garrick . Director of Strategy and Quality Development . Material exceptions to report • Overall Trust performance improved to 67.2%

• Short-term and Long-term sickness improved to 2.26% and 2.96%, respectively. • Sickness performance is consistent with the seasonal trend seen in previous years. • Future figures will clearly be affected by COVID-19 related sickness.

22

Responsible Director: Chief Workforce and International Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Latest

UHB 2.39% 1.98% 1.51% 1.42% 2.00% 1.86% 1.85% 1.86% 2.28% 2.34% 2.21% 2.44% 2.26% 2.26%

Short-Term Sickness Latest Month: 2.26%

1.5%

Short-Term Sickness

Workforce

0.0%

0.5%

1.0%

1.5%

2.0%

2.5%

3.0%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB

Responsible Director: Chief Workforce and International Officer Target:

Feb 19 Mar 19 Apr 19 May 19 Jun 19 Jul 19 Aug 19 Sep 19 Oct 19 Nov 19 Dec 19 Jan 20 Feb 20 Latest

UHB 2.72% 2.78% 3.21% 3.16% 2.80% 2.94% 3.04% 2.93% 2.96% 3.04% 3.44% 3.16% 2.96% 2.96%

2.5%

Long-Term Sickness

Workforce

Long-Term Sickness Latest Month: 2.96%

0.0%

0.5%

1.0%

1.5%

2.0%

2.5%

3.0%

3.5%

4.0%

Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20

Target UHB